Vanguard Group’s Roivant Sciences ROIV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $443M | Sell |
39,326,336
-1,441,254
| -4% | -$16.2M | 0.01% | 1101 |
|
|
2025
Q1 | $411M | Sell |
40,767,590
-3,319,697
| -8% | -$33.5M | 0.01% | 1097 |
|
|
2024
Q4 | $522M | Buy |
44,087,287
+2,404,232
| +6% | +$28.4M | 0.01% | 1017 |
|
|
2024
Q3 | $481M | Buy |
41,683,055
+33,491,231
| +409% | +$386M | 0.01% | 1066 |
|
|
2024
Q2 | $86.6M | Buy |
8,191,824
+85,492
| +1% | +$904K | ﹤0.01% | 1902 |
|
|
2024
Q1 | $85.4M | Buy |
8,106,332
+1,030,681
| +15% | +$10.9M | ﹤0.01% | 1946 |
|
|
2023
Q4 | $79.5M | Buy |
7,075,651
+1,473,085
| +26% | +$16.5M | ﹤0.01% | 1979 |
|
|
2023
Q3 | $65.4M | Buy |
5,602,566
+3,440,374
| +159% | +$40.2M | ﹤0.01% | 2008 |
|
|
2023
Q2 | $21.8M | Buy |
2,162,192
+393,350
| +22% | +$3.96M | ﹤0.01% | 2553 |
|
|
2023
Q1 | $13.1M | Buy |
1,768,842
+119,943
| +7% | +$885K | ﹤0.01% | 2794 |
|
|
2022
Q4 | $13.2M | Buy |
1,648,899
+75,324
| +5% | +$602K | ﹤0.01% | 2827 |
|
|
2022
Q3 | $5.07M | Buy |
1,573,575
+57,226
| +4% | +$184K | ﹤0.01% | 3320 |
|
|
2022
Q2 | $6.17M | Buy |
1,516,349
+196,850
| +15% | +$801K | ﹤0.01% | 3259 |
|
|
2022
Q1 | $6.52M | Buy |
1,319,499
+159,787
| +14% | +$789K | ﹤0.01% | 3385 |
|
|
2021
Q4 | $11.7M | Buy |
+1,159,712
| New | +$11.7M | ﹤0.01% | 3130 |
|